Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A11QVV0
Mon, 13.01.2025
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
HDP-101 is well tolerated to date, with no signs of dose-limiting toxicities
Complete remission observed in one patient from Cohort 5
Proprietary novel payload with a unique mode of action, representing new [ … ]